{"transactions":[{"id":718487,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:34:09.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":36818,"price":0.1921,"value":7072.7378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the \"ESPP\"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP."}],"balance_after":60868,"source":{"system":"sec-edgar","filing":"0001924908-26-000007","document":"form4-07022026_080703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000192490826000007/form4-07022026_080703.xml","form_type":"4"}},{"id":811647,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-04-10T00:33:03.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":56247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":56247,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":56247},"source":{"system":"sec-edgar","filing":"0001924908-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000192490826000005/edgardoc.xml","form_type":"4"}},{"id":811646,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-04-10T00:33:03.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":18753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":18753,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":18753},"source":{"system":"sec-edgar","filing":"0001924908-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000192490826000005/edgardoc.xml","form_type":"4"}},{"id":1098073,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-01T21:50:42.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":7541,"price":1.7,"value":12819.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":24050,"source":{"system":"sec-edgar","filing":"0001415889-25-018755","document":"form4-07012025_090738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588925018755/form4-07012025_090738.xml","form_type":"4"}},{"id":1101799,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:15:07.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the \"Grant Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date."}],"balance_after":100000,"derivative":{"exercise_price":1.96,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-018201","document":"form4-06252025_050603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588925018201/form4-06252025_050603.xml","form_type":"4"}},{"id":1463473,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHF CORP DEVEL OFF, GEN COUNS"}}],"security":"Common Stock","published_at":"2024-07-02T22:07:53.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":4854,"price":2.958,"value":14358.132,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended."}],"balance_after":16509,"source":{"system":"sec-edgar","filing":"0001415889-24-019022","document":"form4-07022024_100750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588924019022/form4-07022024_100750.xml","form_type":"4"}},{"id":1468852,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHF CORP DEVEL OFF, GEN COUNS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T01:30:57.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the \"Vesting Start Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date."}],"balance_after":170000,"derivative":{"exercise_price":3.23,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001415889-24-018278","document":"form4-06272024_010654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588924018278/form4-06272024_010654.xml","form_type":"4"}},{"id":1693360,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHF CORP DEVEL OFF, GEN COUNS"}}],"security":"Common Stock","published_at":"2024-01-03T22:19:38.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":167,"price":1.717,"value":286.739,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan."}],"balance_after":11655,"source":{"system":"sec-edgar","filing":"0001415889-24-000350","document":"form4-01032024_100124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588924000350/form4-01032024_100124.xml","form_type":"4"}},{"id":1836880,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2023-07-05T20:05:12.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":167,"price":1.5895,"value":265.4465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\")."}],"balance_after":11488,"source":{"system":"sec-edgar","filing":"0001415889-23-010720","document":"form4-07052023_040703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588923010720/form4-07052023_040703.xml","form_type":"4"}},{"id":2178495,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-19T19:45:10.000Z","date":"2022-08-17","kind":"purchase","acquired":true,"shares":300000,"price":0.1697,"value":50910.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1689 to $0.1701, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":334629,"source":{"system":"sec-edgar","filing":"0001415889-22-008894","document":"form4-08192022_030801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588922008894/form4-08192022_030801.xml","form_type":"4"}},{"id":2284656,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32993,"kind":"person","name":"Adler Reid G.","position":1,"cik":"0001924908","reported_name":"Adler Reid G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Stock Options (right to buy)","published_at":"2022-05-03T21:10:46.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest on May 2, 2023 (the \"Vesting Start Date\") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date."}],"balance_after":200000,"derivative":{"exercise_price":1.28,"expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-22-004542","document":"form4-05032022_020513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924908/000141588922004542/form4-05032022_020513.xml","form_type":"4"}}]}